Third-party funding

  • DDHD (EU_EFRE; 2018-2022): Drug Discovery Hub Dortmund
  • CANTAR (NRW network program; 2022-2026): Cancer Targeting Network
  • NAVIPP (EU_HORIZON-HLTH; 2024-2028): New AntiVirals for Infections with Pandemic Potential
  • TACTIC (German Cancer Aid; 2024-2029): Targeting Transcriptional Addiction in Cancer
Web-View
Print Page
Open in new window
Estimated DIN-A4 page-width
Go to Editor View